干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
干细胞之家 - 中国干细胞行业门户第一站 干细胞之家论坛 干细胞文献资源库 经典PDF电子书下载区 再来一本病毒学经典--Virology:principles and applicat ...
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 706931|回复: 270
go

[干细胞与细胞生物学类] 再来一本病毒学经典--Virology:principles and applications--John B. Carter  

Rank: 4

积分
1343 
威望
1343  
包包
387  

金话筒 优秀会员 热心会员 小小研究员 积极份子 帅哥研究员

发表于 2011-7-14 17:27 |显示全部帖子
本帖最后由 细胞海洋 于 2011-7-14 22:01 编辑
6 [2 r; K/ a' L& c6 k
3 U2 ?1 F5 f, _- H# N, g2 C [hide][/hide]0 m* W# J7 z6 ]
Virology - Principles and Applications1 q5 X2 c' I# a  |- x% ?6 i
Dr John Carter (Liverpool John Moores University, UK), Prof Venetia Saunders (Liverpool John Moores University, UK): B$ B$ W4 A- W& s$ D6 I6 D. Y: _
August 2007, ©2007
+ y5 d, @( C4 B2 P* C% ]1 }. sby Dr John Carter, Prof Venetia Saunders5 O& J, }8 y- a- W8 ]/ L
ISBN 978-0-470-02387-7
% i5 i$ h) q6 w0 V( w, LPreface." X% N2 F) L+ z2 b8 ?; j/ A
$ r5 I0 a, O) X' X( @
Abbreviations used in this book.
! Y  D' X* l. p, @+ w3 C! p/ ^$ X' l
Greek letters used in this book.
6 q! x) o* y# _% w: z- ]3 ~: ?, O1 Y9 w/ f
Colour coding for molecules.
: I4 J: w( s1 V  X$ S8 R4 d% K2 f2 {# K2 ]: x
1 Viruses and their importance.
. h8 B7 d) [3 @) p1 u" |3 I+ {: ?2 n" }: a
1.1 Viruses are ubiquitous on Earth.* H3 }2 l9 K/ `. ]
- v9 \$ d1 T; \4 ?
1.2 Reasons for studying viruses.& g# B2 U3 m# p3 A$ z2 v

% B% I. `& T4 Y" f( J1.3 The nature of viruses.
. L  R# {' x, h- |( C
+ K) F* i, ~# I* s0 r" v1 m1.4 The remainder of the book.
, }' K. O' Y& M! o( M
. V5 R" {9 |7 N& D2 Methods used in virology.
/ L2 o2 V4 c# W/ u
& A* T/ [0 G1 V. i2.1 Introduction to methods used in virology.! z4 e9 A8 Z6 D2 f( J

% m$ Q. r* q+ Z2.2 Cultivation of viruses.9 I8 f4 u7 x3 F5 _" w" w2 }

+ J# e$ b* v6 M) n2.3 Isolation of viruses.
4 U1 e% c3 U( ]+ `# r* h0 ?3 l. f3 p  u5 P  P: x
2.4 Centrifugation.) _4 r9 ~$ ]8 w3 J

! H4 h" n/ p: X0 b! w0 t2.5 Structural investigations of cells and virions.
6 Q9 s2 q! n0 F5 A" b& s/ Q- t3 F% D) l2 u! H1 i1 Y9 y( w
2.6 Electrophoretic techniques.3 P/ h5 J! }& m
- I5 W& F7 j6 X4 K8 d
2.7 Detection of viruses and virus components.
. z% i5 Z/ P- Z+ M. n0 Q8 A
  \9 D' F3 k8 @/ {& a2.8 Infectivity assays.7 |0 U0 D, ?4 t8 c$ i- V* O8 x. Y  |
1 Z4 K+ C/ m% Y8 Y
2.9 Virus genetics.' P' K$ s1 b5 m7 x9 C

- b$ y; `% y( w8 v9 @( e3 Virus structure.3 o1 e: j# f: `$ p* q

# h6 b( y1 s# S: c2 Y' \3.1 Introduction to virus structure.; ^9 Y2 Q# T& M1 T$ ?& |
3 W- n; s. {* g; C2 W/ Q
3.2 Virus genomes.: h  u, b2 ?: E$ x
) l% f1 P: Z  P& e. {
3.3 Virus proteins.
6 x8 f" `. q1 a4 T2 T9 ~, m1 F- a  A9 g4 g2 F7 `
3.4 Capsids.! T7 l# O2 Y& U* u4 H7 W# {& {) T
& E3 N7 |# K4 G+ S: r4 W5 s
3.5 Virion membranes.
0 g% Y+ a( W; f# h3 R: G! g/ z8 e  ^" n' x7 R" ]. n' i7 x, `1 o4 `0 h% b# e
3.6 Occlusion bodies.( R' B# j( n8 t( _. J! ?) Q

; v# m  F/ ]( r. E' k$ {3 y3.7 Other virion components.% U; p9 U# X! w9 G% q0 i- M/ s
. i: ?" W* l0 C' V; O: b, U. J
4 Virus transmission.. }& \" Y/ h$ Z& E) C$ X# D% M
+ \, P$ {. V0 u0 ]5 n  R' P
4.1 Introduction to virus transmission.! n& F7 l! ~4 c) M7 N3 s

4 o# s0 f" `4 Z2 ]" W5 A7 N4.2 Transmission of plant viruses.
% O. ?9 ?$ d  N7 k8 n  X& g, }# y) u: q1 o% ~. n, B  R6 m
4.3 Transmission of vertebrate viruses.
, J$ E! ^& e8 H6 y
+ [$ @9 Z1 i/ Q; \- T! G4.4 Transmission of invertebrate viruses.8 [8 P7 m; G  W; Z2 V

; t8 g' [1 T9 A0 |! J0 @' M8 N& e4.5 Permissive cells.
! l$ Q; q$ Y( S1 T1 Q+ \% O9 {+ s0 A! d( P0 {- Y0 h! T
5 Attachment and entry of viruses into cells.; _6 d" M* h0 ^

1 y5 n! k4 J  m% W  t" k5.1 Overview of virus replication.
* D8 u( z9 L2 ^- M; r& a; i, q1 ]2 W  y/ p- a4 P
5.2 Animal viruses.! p4 Y1 K" u3 O, P9 U- g, B: b: X( T& x

! ?0 S+ u" R; {4 i) f/ R5.3 Bacteriophages.& l& A8 ~+ c( E
$ s" L& l  {0 ]# \
6 Transcription, translation and transport.
& Y( F/ S! M' e+ h6 @0 S6 x. f
4 \9 M2 ]! W' b- x1 H# i6.1 Introduction to transcription, translation and transport.
  l6 u) D  ?6 z: S1 @; }* V* Y) h4 V0 ~) `. \6 m
6.2 Transcription of virus genomes.
8 m4 e! N- L" d
! V! ~3 n' p' i; k4 s5 [; k6.3 Transcription in eukaryotes.
0 |" m2 Q$ X# v& s# R9 N  [
/ o# d: n: k9 {3 [2 \. v. w4 l% R! q% {6.4 Translation in eukaryotes.
& F+ U1 s1 R. ~  }5 x( M' e* i' t  Q! u: K
6.5 Transport in eukaryotic cells.
' u( k; f# H2 F" F+ s" o" T8 T8 R4 ~1 a$ M
6.6 Transcription and translation in bacteria.
" Y9 ]: {0 X  s' Y$ r8 v5 h) d8 w0 Y4 x; T' d6 ]
7 Virus genome replication.
$ w4 d: x( V* v4 q- G( Y3 c* l5 h& B
7.1 Overview of virus genome replication.4 x5 H) Q! V0 @$ f1 [% v( O

; u+ |9 p9 g6 t7.2 Locations of virus genome replication in eukaryotic cells./ K9 N0 o9 Y2 S* |* G/ O0 S6 p/ d
( i, r% _; i# s5 b: \- ]4 r$ N
7.3 Initiation of genome replication.5 }% ~, |! V, d8 o* x( n

7 j* `  S, R& o, Q9 Y" ]7.4 Polymerases.
! q, |. p/ J0 K/ X5 y  f8 W5 O9 R8 X$ S& e- y
7.5 DNA replication.: R0 r1 g% m% v7 W" w  a

3 i7 M  W/ r9 }$ O+ s4 [: F7.6 Double-stranded RNA replication.% g5 a; h+ B) S/ t2 w8 u- O* g
$ x$ q5 n4 J% N
7.7 Single-stranded RNA replication.
3 ?3 ^4 x5 L" n  ]/ b& n8 }& ?+ M
9 R( @( I2 i: a6 K9 _7.8 Reverse transcription.
6 \( s2 ^  M3 t
% G6 x; ^9 W: T8 c; N( z8 Assembly and exit of virions from cells.
6 m! z: g( g" h: H! Y' `$ o6 Y0 |* }* a( ?' F  c" O5 b6 F+ G
8.1 Introduction to assembly and exit of virions from cells.
. C. _8 O/ E+ c9 O6 \, p. c. i' _+ a, Q; ?: z& ]2 F# w! j; ~, K( a
8.2 Nucleocapsid assembly.& A  g+ o) ~* r/ l; F

  X; p  \0 e; O4 ?8.3 Formation of virion membranes.% n" ^! L/ i* r' J% N

" y7 a: q6 @' q$ @1 v! c8.4 Virion exit from the infected cell.1 M2 ]4 V! q/ v2 _' @. S

; F- e5 P7 }4 ?( l3 {9 Outcomes of infection for the host.
2 y( |* E8 }& K: l1 ]/ Z" z4 ?/ C, u/ _7 {6 ^
9.1 Introduction to outcomes of infection for the host.% Y- j- T1 Q7 r9 Z# M

" O+ Q' }2 M8 m5 \; a9.2 Factors affecting outcomes of infection.5 G( `8 T- l& J1 O

8 ^# G; }. V& E5 l: b/ j3 g9.3 Non-productive infections.
. j: T! ^/ m7 Z$ A: d) p  o
6 h' W. x# t* u, }8 ~9.4 Productive infections.3 }$ Z1 n0 z" p0 d5 a; b

7 f, C) X6 J8 t! Z- h. M( Z10 Classification and nomenclature of viruses.8 J  ?9 p; b4 b5 Q
5 d: d- P1 }7 X
10.1 History of virus classification and nomenclature.
* ?6 h/ p/ D6 [/ c  q3 p  o  h! w% T0 V& B  l. d
10.2 Modern virus classification and nomenclature., e2 _. J0 e, V% @$ e2 F# X

& u8 q4 g8 K9 }3 e+ e# ~10.3 Baltimore classification of viruses.! F+ J! n- A3 e  C3 A% N

: p" N8 P- g% N, V11 Herpesviruses (and other dsDNA viruses).
! G1 L4 D  F9 A( h3 |5 [* U( k2 E4 q* Y  G4 q
11.1 Introduction to herpesviruses.
9 B; [, c) h- Y2 K5 P' U) Z& C5 R/ o% a7 Y* c4 k
11.2 The human herpesviruses.
: L; s1 ?+ G/ Z- T3 R+ d
. f, @# l& i7 z! |8 C11.3 The herpesvirus virion.+ N" e1 D( s' }. M1 e

/ d& ?) y# m+ G+ q  T11.4 HSV-1 genome organization.
0 N) ?; [6 o8 _& w. d
  ?+ I( @, a/ E3 m' \11.5 HSV-1 replication.
9 \) p9 g$ Z. }* y% G. y
; s4 h( J' ?% k, I11.6 Latent herpesvirus infection.# O8 U1 o. h2 y# A% {# u
8 G1 E* Y5 x& x  x; `2 e
11.7 Other dsDNA viruses.
* k2 k$ V0 J4 h/ s' Y% W1 O8 q& h4 g4 s9 t0 c+ G) |" c
12 Parvoviruses (and other ssDNA viruses).
  d# q" ^/ L2 P( `
7 N( o* y- f6 v. ]  ~- y; ]12.1 Introduction to parvoviruses.
' z8 w2 B$ R5 d* \! t9 T! r
* r% C7 b  o( [. K: L6 J+ H12.2 Examples of parvoviruses.: e, x! d) X" F) q

, A' u: F) g3 M2 V4 \# e( Q0 o% L12.3 Parvovirus virion.' [* E# }* T' s8 ~5 M0 q

% L- X! i" H! ~4 Y, F12.4 Parvovirus replication.
$ V8 Z/ e+ o! }& G! r. `" i; A3 p8 \* f5 h, c4 U7 B1 v
12.5 Other ssDNA viruses.
. m, B( X" ?3 ^! V0 b) C* ~: P& [& B3 }$ ~6 O6 z, j4 B5 E- d5 c, ~
13 Reoviruses (and other dsRNA viruses).
7 j% A) ~0 a; e5 L# e/ x+ M! g6 k  }5 E  U* U
13.1 Introduction to reoviruses./ G5 @1 l1 E6 F9 o9 p

1 F$ _. c; O- E2 ?) p, w13.2 Rotavirus virion.
% E! D, {  X0 b9 t& w2 L8 w2 j: u: V2 k6 f, @
13.3 Rotavirus replication.% E4 T: }2 Q& f7 C/ m$ d0 f
. m5 l! Z8 ^# K0 k" n
13.4 Other dsRNA viruses.) g% E- A5 E; ]. M
+ l" Q9 R' ]/ j" N
14 Picornaviruses (and other plus-strand RNA viruses).' s1 ]: F4 t) X0 }
% V' m  J8 P! j  C* m9 m
14.1 Introduction to picornaviruses.
: g0 S/ Z/ v5 f; e2 V; p) f- ?2 V
$ `; F. X5 M: |/ J" _6 `14.2 Some important picornaviruses.1 J* C! k0 N8 X$ B
6 i8 C2 M; b: `2 m4 z
14.3 The picornavirus virion.2 O2 f/ q" K7 W

8 t* Z7 e0 \7 x) L: H14.4 Picornavirus replication.
/ j$ K# p( \5 n8 ^/ T( H
; q! T7 a. F4 y" x, }$ S14.5 Picornavirus recombination.
' T. g: w8 Z* q! x' e8 c8 ]' O" i3 X4 W5 E& o
14.6 Picornavirus experimental systems
) V8 N' i' `+ s9 e- q2 ^" I4 I& }* @8 i1 ~5 A
14.7 Other plus-strand RNA viruses.
" ~# ]0 F! n0 ~" z/ F2 b0 o
/ J. Z+ j0 B6 @  N7 r( V. W  z15 Rhabdoviruses (and other minus-strand RNA viruses).
6 C, [. F3 Q: M4 {2 x0 e
1 B* R+ Q, T+ M$ S+ V) Z7 b% {9 [15.1 Introduction to rhabdoviruses.
* T. ?: g0 y, r- h( w; g4 r' ?/ Q0 s+ C: d: K
15.2 Some important rhabdoviruses.
2 w8 L) X# @& w: J$ Z& e) v
) B9 H: S( H  t( [15.3 The rhabdovirus virion and genome organization.: T- B! O) d1 U9 ]! g

9 N$ {- R; |. P$ c' a) o15.4 Rhabdovirus replication.9 V" B& L7 p$ u0 S: y" y
3 M- b/ W, _. Z, o
15.5 Other minus-strand RNA viruses.
# x2 ^$ K( Z8 _2 ~6 N$ ^# j4 @  e. Z. ~
15.6 Viruses with ambisense genomes.
& J) _: E9 V8 h; K
+ P! r& E8 |. B6 q& z: Y* x15.7 Reverse genetics.
5 f1 \" y% Z% o$ Q
' b! c6 ~  c) r+ |16 Retroviruses.
6 k) T1 X/ U5 S' R, `; b+ `# K" D7 C' z$ ]" a
16.1 Introduction to retroviruses.: @, |# m" u* `
" L8 d" n7 |% t. e; q3 T
16.2 Retrovirus virion.1 `! \# }5 g# o0 T
; {% D6 x# x# x/ R* e
16.3 Retrovirus replication.: w3 h1 O8 D4 h: z) R+ K
' W/ e/ s! m8 G! Q  T
16.4 Examples of retroviruses.
6 S4 Y$ I- ?6 L( o3 T, s! Y' B- V/ U: R) Z$ y  l, U7 r
16.5 Retroviruses as gene vectors.
# `  [+ l4 v( B7 u1 b6 j9 B2 Q1 [# x. [" M1 v& S; Q# O8 v
16.6 Endogenous retroviruses.
( b- ^0 E6 d8 E- |
# ?8 E6 d8 J1 {8 B; {17 Human immunodeficiency viruses.
4 E3 ?* H" m- n. K- C* ?" u* H) ]1 h' a0 k
17.1 Introduction to HIV.
3 _4 k/ O7 _. K9 n  ~3 J
+ ]% B, |& E- A: _3 K17.2 HIV virion.
4 Q, d/ p, s8 q2 i) y1 L
; f. ]8 T7 y/ h17.3 HIV genome.
9 s' o& v* V8 E4 E( d
. F8 A0 k1 U7 N  x6 ^17.4 HIV-1 replication.
6 w; M8 O- v8 _( s5 A1 s% J6 d
/ W6 B0 }' s) x& e& f* ~17.5 HIV-1 variability.
8 V9 F: Q8 l* R  ?5 H) k
8 n1 q% U3 ^8 ?) v2 g17.6 Progression of HIV infection.- t, N; X4 c, k5 Z

( b% x  q3 g" C6 f: ^" l17.7 Prevention of HIV transmission.
2 w% c5 \0 U" U
* a' C4 D; r! @1 F1 ?18 Hepadnaviruses (and other reverse-transcribing DNA viruses).
& Q; y  o  d5 \* i/ |' N
. Z, V# J! S; V8 e7 Y18.1 Introduction to hepadnaviruses.$ d- w9 \( V% {: e' ~; \

4 o: U3 F1 s( Y6 X6 w# X" e18.2 Importance of HBV.
: c6 P2 M$ ^: Y4 K2 n/ F, f7 ~4 P, P
18.3 HBV virion.
( O9 O; K% _8 U6 g; P
& C+ s, {& p5 \2 a& e7 F. ?7 y/ X18.4 Non-infectious particles.
" t2 T) O0 v0 Y' O6 b% n8 y( s! Z# b2 [& {! w
18.5 Soluble virus protein.+ f; T& B) z9 g0 ]2 W$ c

& F9 U7 R  W! \- J18.6 HBV genome.
, i% W( `3 J  `# @1 G4 V, A
- D1 L( \  C# _18.7 HBV genetic groups.% A% s  r4 `: S* F: s6 |

! c0 X+ b. \, B2 y; B& C  f* ~8 w18.8 HBV replication cycle.
, D' H9 l! h& X
+ D1 Q7 f% A" f& G  V18.9 Prevention and treatment of HBV infection." X) \- V/ y0 u* a

5 F# Q; W8 B1 f+ {18.10 Other reverse-transcribing DNA viruses.! g) C. c" b2 a: P7 D& K

2 ]8 D* l* g: }1 H7 n  K1 r) B; i19 Bacterial viruses.
0 N" E& m- `7 O6 O
! F; C" j  r* e& t19.1 Introduction to bacterial viruses (bacteriophages.( d" ]# h% T8 V# T

8 F) \* R# W; Q2 m) G, y/ ARNA PHAGES.: o5 G2 O$ G1 Q+ q  h& p" n( \( R, r

7 ~- s7 G  H3 w19.2 Single-stranded RNA phages.4 ~% C9 r3 ?1 K) u
% L, w) `6 i. v/ s- O! B' M
19.3 Double-stranded RNA phages.& }8 A) E+ u$ i
! t2 ?. s9 y( E; k0 O
DNA PHAGES.$ O, R5 k# Z, B5 L+ k: Y' g
/ U! s0 G! g2 W' k/ Q  Q
19.4 Single-stranded DNA phages.
! x$ t- h2 M2 h5 J6 E9 |& B" l/ t/ p+ N6 a
19.5 Double-stranded DNA phages.8 v+ }6 j9 l/ y# N

6 _# C/ Z7 I& l, |7 C% a4 t20 Origins and evolution of viruses.
# R8 `; \8 h/ v! W: h; `8 ?- ]: x0 V) h2 l! C' K( r! u- T
21.1 Introduction to origins and evolution of viruses.
* _% z' _6 }$ S; x2 Z( G8 a  h& k% |% l' i* R* q
20.2 Origins of viruses.4 ]) s% w& w) t. i
0 P  W% K# f0 [& g* i
20.3 Evolution of viruses.! V; M" t: \* k" y8 i
1 r/ O) ]# L% e1 G& p( ^
21 Emerging viruses.: z. J  _, u3 Z7 R5 r4 D' U
5 v7 F2 a4 `7 m& p7 o5 O/ s
21.1 Introduction to emerging viruses, S! t+ }4 a9 }+ Z  _/ r8 w

8 A& t2 z# K  C7 B1 I% Q1 ^21.2 Viruses in new host species
' Y2 y+ ]% j4 Y) O) }5 B" i$ A* u0 ~& w( [% ?) z5 B- l
21.3 Viruses in new areas& F. w( I' p. b. j, d' E5 i
. r; ^5 i! ~: W2 x% K
21.4 Viruses in new host species and in new areas- m4 L: N; D- b3 r- g. e
! a5 I5 x; \) F; W' }
21.5 New viruses
1 |  E7 z% |/ Y) A( Z5 b& V8 Z
7 t( ]! D: o  [/ ~% u21.6 Recently discovered virus
; B  M: M* Y! M, n, t8 ~( h1 ?! g+ Z* i) C6 ^: B
21.7 Re-emerging viruses
" w* ]0 H4 {4 o9 [4 ^0 I3 `7 b
4 `5 I. E0 E6 d9 m; l9 [21.8 Virus surveillance
. s# x7 n8 K1 ?$ x, a) N" t" D9 z- M0 A( J
21.9 Dealing with outbreaks
1 ~. r# s$ P% J+ |0 |
5 s# H+ X' y% d- y. I22 Viruses and cancer- P( s$ g5 `1 ?3 S4 T

2 _3 [0 O  Y' X1 W9 p7 I: k, S22.1 Introduction to viruses and cancer
  V. y) L1 u& \) g% |2 X; |( Z: S' Z& t
22.2 Papillomavirus-linked cancers
$ Y: P. V# W! u! n) x  R0 G- P7 s! L7 ~6 V# v. v
22.3 Polyomavirus-linked cancers9 a8 X9 o, j3 m# r/ P1 k' _
% c6 s3 K3 ?. S, r
22.4 Epstein-Barr virus-linked cancers' d. G" b6 l+ N( F
0 A: a% r0 Z9 l/ g
22.5 Kaposi’s sarcoma. H6 M; ^6 V) }

. F/ [6 E1 p6 w  `* D* Q22.6 Adult T cell leukaemia
; q9 h6 a) G1 L+ i7 {
  g- d& [/ H; x; I; @1 g22.7 Hepatocellular carcinoma3 a4 n% Z: h2 U
) M+ A3 b, j4 N
22.8 Virus-associated cancers in animals: @. X, V+ T0 y
& F: n7 _! M: g! v+ {) _
22.9 Cell lines derived from virus-associated cancers.
6 _& e3 l  [1 L" ?6 m& C1 z4 p- \& |& j- p
22.10 How do viruses cause cancer?
9 p# I5 M5 b. C" i' ^
; Z4 N1 x  v% Q& F: H; _22.11 Prevention of virus-induced cancers.
2 e, W& }/ Y6 k. Y0 ~- ^* Y& n& D7 ^
% O! J; K- z+ i! R2 j: y( r23 Survival of infectivity.) g' h& f+ J# D  I1 T

3 \' e! K4 S* k0 u23.1 Preservation of virus infectivity.
% q! I$ [/ H3 o$ K9 o$ {7 b/ _( D8 B- z5 M7 j& ^/ i2 }& x
23.2 Destruction of virus infectivity.
: w# a% a" z5 n/ F) S6 S" |4 C6 L; {: o6 |: n
23.3 Inactivation targets in virions.
3 U! }# E8 s- D, ^  L1 X
( I' d) c8 W& y3 x4 k0 k23.4 Inactivation kinetics.
7 `1 T  p; ^: [  F, X
& @" V2 a3 W& c7 b  ?! I) ~23.5 Agents that inactivate virus infectivity.
8 R2 Q8 r: k: h; N  n$ C! z. k# g' v7 `7 n& I( k
24 Virus vaccines.+ _# P+ Q9 f* |: Q

, q$ u" S  \- `0 K8 E- M. Y24.1 Introduction to virus vaccines.' b- o; P6 ?* m% ~% N

9 v3 x! }! b) [  |24.2 Live attenuated virus vaccines., Q# H% D' w5 Z- x

3 @9 J# o2 z$ M/ q8 Z4 P: Z24.3 Inactivated virus vaccines.
+ M+ N3 ~- q% x' n' n% P
: o" P* @7 H. B, h24.4 Virion subunit vaccines., ^( k4 I0 }7 a- s6 ?- O' h: z
0 o, L( f3 }8 U' n" h- p! }
24.5 Live recombinant virus vaccines.  f( C6 H6 P, H4 C. R
) Q4 \' O1 {" C
24.6 Mass production of viruses for vaccines.
6 J" q( M) ^" H5 n% S
: U& I3 j) ^5 K9 z6 w1 J- ^24.7 Virus-like particles.% w) s. W0 s. v. n" {
8 V' ]0 w# {% f
24.8 Synthetic peptide vaccines.1 k5 [, t0 z& v4 t
, \/ o$ H9 z# u& ^0 @" Y/ m
24.9 DNA vaccines.
- A3 [8 U7 z, r( e/ l, W& O
! l8 P3 D" ~4 T# l" q24.10 Storage and transport of vaccines.
$ ~+ ~9 ~3 X  q6 Q  K
( B5 C/ J& N, R: y* m$ i25 Anti-viral drugs.0 W$ C0 b% L, t
) S$ _/ G3 v$ z/ k8 p
25.1 Introduction to anti-viral drugs.
' k. I* W; @3 T( _, D* K, c% D* t  L9 a' `
25.2 Development of anti-viral drugs.1 {+ G9 K; _! \9 c! e6 t
( \) e" b$ I+ V
25.3 Examples of anti-viral drugs.% e/ l* k, D, ~$ L
5 U% f7 ^+ m; R4 X+ M1 Y  y
25.4 Drug resistance.( ^' g6 [& k1 g! [) I' B

8 P, ]+ q8 S& o  `, R25.5 Anti-viral drug research.
" F! @6 W, w; e( q* E) W
  K( U8 a7 Y7 _6 z7 q# w; K* x26 Prions.* y  x+ L& K, H) l# u

+ X7 ?2 B( H) }8 ^26.1 Introduction to prions.
% g/ u  ?; i2 q, z* K
/ ]$ j& a6 H8 {# O9 W26.2 Transmissible spongiform encephalopathies.
. W4 Q' w3 h* H) C3 v
% P! Z7 E* ]' E26.3 The nature of prions.7 o# }! i% C  `+ b, A) H

/ b; v) [; g- O6 k& u. _" L9 {- Q26.4 Prion diseases.
7 h) T0 P9 k( [1 w; E
% N6 F1 L- ?3 a. J4 i8 f7 b5 I26.5 Prion strains.1 z7 m6 r" u* m4 G- a

8 A0 X) e: ^9 B7 F4 c- r2 M26.6 Prion transmission.
6 J1 i. I4 X' d7 k$ A) i6 R% I7 U: m* e5 i. Z
26.7 The protein-only hypothesis.
8 O* l7 g( a" M- N# h5 j# c
' B3 V! I* Z0 y4 A8 mLearning outcomes.
% V- u9 y. F8 r7 E9 P$ C( C3 y2 `' ^
Sources of further information.' C9 e" `$ r0 S% z9 ?

0 l: f7 e8 {% [5 xVirologists' vocabulary.
5 K) e; z6 Y& F* P, \# F$ h  F( n- K
; q6 S- `: V" y! F5 j; u. yIndex.
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
已有 2 人评分威望 包包 收起 理由
aminhair + 2 + 5 经典书,帖子格式好!
细胞海洋 + 2 + 10 极好资料

总评分: 威望 + 4  包包 + 15   查看全部评分

Rank: 3Rank: 3

积分
364 
威望
364  
包包
131  

优秀会员

发表于 2011-7-14 19:01 |显示全部帖子
好书!

Rank: 7Rank: 7Rank: 7

积分
947 
威望
947  
包包
3255  

金话筒 优秀版主

发表于 2011-7-14 19:20 |显示全部帖子
回复 dahui 的帖子
% e& S" }! e8 _) O* G* j7 Y. _# r3 L4 C4 P* ?( X
看看

Rank: 3Rank: 3

积分
318 
威望
318  
包包
7  

优秀会员

发表于 2011-7-14 20:47 |显示全部帖子
干细胞之家微信公众号
学习

Rank: 1

积分
威望
0  
包包
15  

优秀会员

发表于 2011-7-14 22:07 |显示全部帖子
kankan

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

发表于 2011-7-14 22:17 |显示全部帖子
3qqq

Rank: 3Rank: 3

积分
410 
威望
410  
包包
39  

优秀会员 金话筒

发表于 2011-7-14 22:19 |显示全部帖子
好书,谢谢楼主分享

Rank: 2

积分
160 
威望
160  
包包
3  

帅哥研究员 小小研究员 优秀会员

发表于 2011-7-14 22:39 |显示全部帖子
谢谢楼主

Rank: 2

积分
234 
威望
234  
包包
197  

优秀会员

发表于 2011-7-14 22:39 |显示全部帖子
好东西

Rank: 2

积分
57 
威望
57  
包包
97  

热心会员 小小研究员 帅哥研究员

发表于 2011-7-14 23:43 |显示全部帖子
kankan
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2024-4-16 23:09

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.